News | July 15, 2022
Novavax statement on EMA Nuvaxovid label update related to allergic reaction
Novavax’ clinical development program reported no severe allergic reactions
Novavax’ clinical development program reported no severe allergic reactions
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Plant is part of the company's CAD $30 million capital investment in the site
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~
Subscribe To Our Newsletter & Stay Updated
